The first global prevalence estimates of autonomic dysfunction in Long COVID are here. The numbers are larger than most clinicians suspect.
∙ Paid
Today let’s decode a meta-analysis published in Frontiers in Cardiovascular Medicine in January 2026 that did something nobody had done before: pooled all available observational data on autonomic dysfunction in Long COVID into a single, properly methodologically rigorous global prevalence estimate. The numbers it produced are striking enough that they deserve a dedicated piece rather than a passing mention.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.